Artwork

Content provided by CIBC Private Wealth - Matt Mammola and CIBC Private Wealth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CIBC Private Wealth - Matt Mammola and CIBC Private Wealth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

COVID-19: Vaccine variables and investment implications

10:20
 
Share
 

Manage episode 264943245 series 2154733
Content provided by CIBC Private Wealth - Matt Mammola and CIBC Private Wealth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CIBC Private Wealth - Matt Mammola and CIBC Private Wealth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this interview hosted by Head of Equities Patricia Bannan, CFA, healthcare analysts Fred Weiss, CFA, and Mac Price, CFA, discuss the rapidly evolving landscape around the creation of a coronavirus vaccine. With 135 vaccine candidates in trials, including 15 already in human clinical trials, and the U.S. government’s Operation Warp Speed program helping to fast-track the vaccine development, manufacturing and distribution, experts have expressed optimism about a timeline for release in 2021. What do our analysts believe are the implications for investors?
  continue reading

45 episodes

Artwork
iconShare
 
Manage episode 264943245 series 2154733
Content provided by CIBC Private Wealth - Matt Mammola and CIBC Private Wealth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CIBC Private Wealth - Matt Mammola and CIBC Private Wealth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this interview hosted by Head of Equities Patricia Bannan, CFA, healthcare analysts Fred Weiss, CFA, and Mac Price, CFA, discuss the rapidly evolving landscape around the creation of a coronavirus vaccine. With 135 vaccine candidates in trials, including 15 already in human clinical trials, and the U.S. government’s Operation Warp Speed program helping to fast-track the vaccine development, manufacturing and distribution, experts have expressed optimism about a timeline for release in 2021. What do our analysts believe are the implications for investors?
  continue reading

45 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide